methyl 5-aminolevulinate has been researched along with Facial Dermatoses in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (17.95) | 29.6817 |
| 2010's | 32 (82.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gonzalez, H; Haedersdal, M; Halldin, C; Sandberg, C; Sørensen, SS; Togsverd-Bo, K; Wennberg, AM; Wulf, HC | 1 |
| Cantisani, C; Eibenschutz, L; Fargnoli, MC; Gaastra, MTW; Hunger, RE; Ibbotson, SH; Kerrouche, N; Medina, S; Pérez-Garcia, B; Rostain, G; Venema, AW | 1 |
| Gupta, M; Kim, EN; Slape, DR; Weller, P | 1 |
| Béhal, H; Deleporte, P; Duhamel, A; Kerob, D; Lecomte, F; Maire, C; Mordon, S; Mortier, L; Thecua, E; Vicentini, C; Vignion-Dewalle, AS | 1 |
| Aschoff, RAG; Chavda, R; Dominicus, R; Gauglitz, GG; Karrer, S; Kerrouche, N; Krähn-Senftleben, G; Szeimies, RM; Zarzour, A | 1 |
| Bierman, DF; Coakley, BJ; Haedersdal, M; Serowka Lane, KL; Shive, ML; Wiegell, SR; Zachary, CB | 1 |
| Calzavara-Pinton, PG; Facchinetti, E; Rossi, MT; Specchia, C; Zane, C | 1 |
| Bosc, C; Foley, P; Hewitt, D; Kerob, D; Kerrouche, N; Murrell, DF; Rubel, DM; See, JA; Shumack, S; Spelman, L; Wulf, HC | 1 |
| Petersen, B; Wiegell, SR; Wulf, HC | 2 |
| Grönroos, M; Karppinen, TT; Neittaanmäki-Perttu, N; Snellman, E; Tani, TT | 1 |
| Bessis, D; Debu, A; Girard, C | 1 |
| Graf, B; Gruber, M; Hansen, E; Heinlin, J; Horner, C; Karrer, S; Kerscher, C; Klein, A; Koller, M; Landthaler, M; Szeimies, RM; Werner, A; Zeman, F | 1 |
| Fargnoli, MC; Neri, L; Pellegrini, C; Peris, K; Piccioni, A; Tambone, S | 2 |
| Fernández-Peñas, P; Foley, P; Hewitt, D; Murrell, DF; Rubel, DM; Salmon, R; See, JA; Shumack, S; Spelman, L | 1 |
| Adamski, H; Basset-Seguin, N; Dreno, B; Gerritsen, MJ; Gilaberte, Y; Girard, C; Kelleners-Smeets, N; Kerrouche, N; Lacour, JP; Leclerc, S; Perez-Garcia, B; Redondo, P; Serra-Guillen, C; Synnerstad, I; Szeimies, RM; Tarstedt, M; Tsianakas, A; Ulrich, C; Venema, AW; Von Felbert, V | 1 |
| Bukhalo, M; Eichenfield, LF; Jarratt, M; Pariser, DM; Waterman, G | 1 |
| Fai, C; Fai, D; Genovese, G; Mavilia, L; Mercuri, SR | 1 |
| Antoniou, C; Dessinioti, C; Drakaki, E; Katsambas, A; Masouri, S | 1 |
| Adamski, H; Basset-Séguin, N; Beaulieu, P; Dreno, B; Girard, C; Lacour, JP; Riboulet, JL | 1 |
| Arisi, M; Calzavara-Pinton, I; Calzavara-Pinton, P; Moggio, E; Zane, C | 1 |
| Arisi, M; Calzavara-Pinton, P; Fabiano, A; Zane, C | 1 |
| Abramovits, W; Bailin, P; Bruce, S; Geronemus, R; Jarratt, M; Loss, R; Pariser, D; Spencer, J | 1 |
| Fernández-Guarino, M; Harto, A; Jaén, P; Marquet, A; Pérez-García, B; Sánchez-Ronco, M | 1 |
| Gerritsen, RM; Kleinpenning, MM; van de Kerkhof, PC | 1 |
| Botella-Estrada, R; Guillen, C; Hueso, L; Llombart, B; Nagore, E; Requena, C; Sanmartín, O; Serra-Guillen, C | 1 |
| Fernández-Guarino, M; García-Morales, I; Harto, A; Jaén, P | 1 |
| Andersen, BL; Berne, B; Brocks, KM; Fabricius, S; Haedersdal, M; Heydenreich, J; Jemec, GB; Kroon, S; Mogensen, M; Mørk, C; Philipsen, PA; Sandberg, C; Stender, IM; Wiegell, SR; Wulf, HC | 1 |
| Campbell, SM; Curnow, A; Morton, C; Tyrrell, JS | 1 |
| Salmon, R; Tran, DT | 1 |
| Brito, C; da Luz Duarte, M; Gomes, J; Ventura, F | 1 |
| Andersen, BL; Berne, B; Brocks, KM; Fabricius, S; Gniadecka, M; Heydenreich, J; Hædersdal, M; Ibler, KS; Jemec, GB; Kroon, S; Mørk, C; Philipsen, PA; Sandberg, C; Stender, IM; Wiegell, SR; Wulf, HC | 1 |
| Barrera, M; Correa, LA; Garcia, HI; Garcia, JJ; Sanclemente, G; Villa, JF | 1 |
| Berne, B; Rosdahl, I; Svanberg, K; Tarstedt, M; Wennberg, AM | 1 |
| Campbell, S; Gupta, G; Keohane, S; Kerrouche, N; Lear, J; Morton, C; Soto, P; Thomas, G; Walton, S; Zaki, I | 1 |
| Morton, CA | 1 |
| Andersen, KE; Hohwy, T; Sommerlund, M; Sølvsten, H | 1 |
| Enk, CD; Eriksen, P; Haedersdal, M; Philipsen, PA; Wiegell, SR; Wulf, HC | 1 |
2 review(s) available for methyl 5-aminolevulinate and Facial Dermatoses
| Article | Year |
|---|---|
Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia.
Topics: Aminolevulinic Acid; Australia; Consensus; Facial Dermatoses; Female; Humans; Keratosis, Actinic; Male; Photochemotherapy; Photosensitizing Agents; Practice Guidelines as Topic; Prognosis; Randomized Controlled Trials as Topic; Severity of Illness Index; Sunlight; Treatment Outcome | 2016 |
Methyl aminolevulinate: actinic keratoses and Bowen's disease.
Topics: Aminolevulinic Acid; Bowen's Disease; Facial Dermatoses; Humans; Keratosis; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Skin Neoplasms; Ultraviolet Rays | 2007 |
23 trial(s) available for methyl 5-aminolevulinate and Facial Dermatoses
| Article | Year |
|---|---|
Photodynamic therapy is more effective than imiquimod for actinic keratosis in organ transplant recipients: a randomized intraindividual controlled trial.
Topics: Aged; Aminolevulinic Acid; Drug Eruptions; Facial Dermatoses; Female; Hand Dermatoses; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Pain; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Treatment Outcome | 2018 |
Photodynamic therapy for actinic keratosis of the forehead and scalp: a randomized, controlled, phase II clinical study evaluating the noninferiority of a new protocol involving irradiation with a light-emitting, fabric-based device (the Flexitheralight p
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Female; Forehead; Humans; Keratosis, Actinic; Male; Middle Aged; Pain Measurement; Pain, Procedural; Patient Reported Outcome Measures; Photochemotherapy; Photosensitizing Agents; Scalp; Scalp Dermatoses; Severity of Illness Index; Treatment Outcome | 2019 |
A randomized clinical trial of photodynamic therapy with methyl aminolaevulinate vs. diclofenac 3% plus hyaluronic acid gel for the treatment of multiple actinic keratoses of the face and scalp.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Cost-Benefit Analysis; Diclofenac; Drug Combinations; Facial Dermatoses; Female; Gels; Humans; Hyaluronic Acid; Keratosis, Actinic; Male; Middle Aged; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Scalp Dermatoses; Treatment Outcome | 2014 |
Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Female; Humans; Keratosis, Actinic; Male; Ointments; Pain; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Scalp Dermatoses; Treatment Outcome | 2014 |
Topical corticosteroid reduces inflammation without compromising the efficacy of photodynamic therapy for actinic keratoses: a randomized clinical trial.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminolevulinic Acid; Anti-Inflammatory Agents; Clobetasol; Erythema; Facial Dermatoses; Female; Fluoroscopy; Glucocorticoids; Humans; Keratosis, Actinic; Male; Pain; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Scalp Dermatoses; Treatment Outcome | 2014 |
Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Double-Blind Method; Facial Dermatoses; Female; Humans; Keratosis, Actinic; Male; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Scalp Dermatoses; Treatment Outcome | 2014 |
Comparing cold-air analgesia, systemically administered analgesia and scalp nerve blocks for pain management during photodynamic therapy for actinic keratosis of the scalp presenting as field cancerization: a randomized controlled trial.
Topics: Administration, Oral; Aged; Aminolevulinic Acid; Analgesia; Analgesics, Opioid; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Cold Temperature; Dipyrone; Facial Dermatoses; Forehead; Hemodynamics; Humans; Injections, Intravenous; Keratosis, Actinic; Male; Middle Aged; Nerve Block; Ophthalmic Nerve; Pain; Pain Measurement; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Pirinitramide; Quality of Life; Scalp; Scalp Dermatoses; Trochlear Nerve | 2015 |
Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Europe; Facial Dermatoses; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Pain; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Severity of Illness Index; Single-Blind Method; Skin Cream; Sunlight; Treatment Outcome | 2015 |
Photodynamic therapy with methyl aminolaevulinate 80 mg g(-1) for severe facial acne vulgaris: a randomized vehicle-controlled study.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Aminolevulinic Acid; Child; Double-Blind Method; Drug Eruptions; Facial Dermatoses; Female; Humans; Male; Ointments; Pain; Photochemotherapy; Photosensitizing Agents; Treatment Outcome; Young Adult | 2016 |
Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Dermatologic Agents; Diterpenes; Facial Dermatoses; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Patient Preference; Photochemotherapy; Photosensitizing Agents; Remission Induction; Scalp Dermatoses; Sunlight; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2016 |
Pulse photodynamic therapy reduces inflammation without compromising efficacy in the treatment of multiple mild actinic keratoses of the face and scalp: a randomized clinical trial.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Erythema; Facial Dermatoses; Female; Fluorescence; Humans; Keratosis, Actinic; Male; Ointments; Pain; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Scalp Dermatoses; Treatment Outcome | 2016 |
A randomized split-face clinical trial analyzing daylight photodynamic therapy with methyl aminolaevulinate vs ingenol mebutate gel for the treatment of multiple actinic keratoses of the face and the scalp.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Diterpenes; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Administration Schedule; Facial Dermatoses; Female; Gels; Humans; Keratosis, Actinic; Male; Middle Aged; Patient Preference; Photochemotherapy; Scalp Dermatoses; Treatment Outcome | 2016 |
A Randomized Split-Face Clinical Trial of Photodynamic Therapy with Methyl Aminolevulinate versus Ingenol Mebutate Gel for the Treatment of Multiple Actinic Keratoses of the Face and Scalp.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminolevulinic Acid; Diterpenes; Face; Facial Dermatoses; Female; Follow-Up Studies; Gels; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Remission Induction; Retrospective Studies; Scalp; Scalp Dermatoses; Skin; Treatment Outcome | 2016 |
Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: A randomized, double-blind, placebo-controlled study.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Double-Blind Method; Facial Dermatoses; Female; Humans; Keratosis; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Treatment Outcome | 2008 |
A randomized comparative study of tolerance and satisfaction in the treatment of actinic keratosis of the face and scalp between 5% imiquimod cream and photodynamic therapy with methyl aminolaevulinate.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aminolevulinic Acid; Aminoquinolines; Child; Child, Preschool; Facial Dermatoses; Female; Humans; Imiquimod; Infant; Keratosis, Actinic; Male; Middle Aged; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Young Adult | 2011 |
[Photodynamic therapy for acne: use of the pulsed dye laser and methylaminolevulinate].
Topics: Acne Vulgaris; Adolescent; Aminolevulinic Acid; Combined Modality Therapy; Facial Dermatoses; Female; Humans; Lasers, Dye; Low-Level Light Therapy; Male; Pain; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Shoulder; Sunscreening Agents; Treatment Outcome | 2010 |
A randomized, multicentre study of directed daylight exposure times of 1½ vs. 2½ h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Dose-Response Relationship, Radiation; Facial Dermatoses; Female; Heliotherapy; Humans; Keratosis, Actinic; Male; Middle Aged; Patient Satisfaction; Photosensitizing Agents; Scalp Dermatoses; Time Factors | 2011 |
Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites.
Topics: Adult; Aged; Aminolevulinic Acid; Analysis of Variance; Extremities; Facial Dermatoses; Female; Fluorescence; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Precancerous Conditions; Protoporphyrins; Scalp Dermatoses; Skin Neoplasms | 2011 |
Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Dose-Response Relationship, Radiation; Facial Dermatoses; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Radiation Dosage; Scalp Dermatoses; Sunlight; Sunscreening Agents; Treatment Outcome | 2012 |
Methyl aminolevulinate plus red light vs. placebo plus red light in the treatment of photodamaged facial skin: histopathological findings.
Topics: Adult; Aged; Aminolevulinic Acid; Collagen; Double-Blind Method; Elastic Tissue; Face; Facial Dermatoses; Female; Humans; Middle Aged; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Skin Aging | 2012 |
A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp.
Topics: Administration, Topical; Aged; Aminolevulinic Acid; Facial Dermatoses; Female; Humans; Keratosis; Male; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Ultraviolet Rays | 2005 |
Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Cryosurgery; Esthetics; Facial Dermatoses; Female; Humans; Keratosis; Male; Middle Aged; Patient Satisfaction; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Scalp Dermatoses; Severity of Illness Index | 2006 |
Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Dose-Response Relationship, Drug; Facial Dermatoses; Female; Heliotherapy; Humans; Keratosis; Male; Middle Aged; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Scalp Dermatoses; Single-Blind Method; Treatment Outcome | 2008 |
14 other study(ies) available for methyl 5-aminolevulinate and Facial Dermatoses
| Article | Year |
|---|---|
Patient and physician satisfaction in an observational study with methyl aminolevulinate daylight photodynamic therapy in the treatment of multiple actinic keratoses of the face and scalp in six European countries.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Attitude of Health Personnel; Europe; Facial Dermatoses; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Patient Reported Outcome Measures; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Physicians; Prospective Studies; Scalp Dermatoses; Sunlight; Surveys and Questionnaires | 2018 |
Leishmania tropica successfully treated with photodynamic therapy.
Topics: Adult; Aminolevulinic Acid; Facial Dermatoses; Humans; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Nose Diseases; Photochemotherapy; Photosensitizing Agents | 2019 |
Methyl aminolevulinate daylight photodynamic therapy applied at home for non-hyperkeratotic actinic keratosis of the face or scalp: an open, interventional study conducted in Germany.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Female; Germany; Humans; Keratosis, Actinic; Male; Patient Reported Outcome Measures; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Self Care; Sunlight; Surveys and Questionnaires; Treatment Outcome | 2019 |
Use of 5-Aminolevulinic Acid and Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses.
Topics: Aminolevulinic Acid; Facial Dermatoses; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Sunlight; Treatment Outcome | 2019 |
Discoid lupus erythematosus successfully treated by photodynamic therapy.
Topics: Administration, Cutaneous; Aged; Aminolevulinic Acid; Facial Dermatoses; Humans; Lupus Erythematosus, Discoid; Male; Ointments; Photochemotherapy; Photosensitizing Agents; Treatment Outcome | 2015 |
Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Female; Humans; Italy; Keratosis, Actinic; Male; Middle Aged; Pain; Pain Measurement; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Recurrence; Scalp Dermatoses; Skin Cream; Sunlight; Sunscreening Agents; Temperature | 2015 |
Short-contact, low-dose methyl aminolaevulinate photodynamic therapy for acne vulgaris.
Topics: Acne Vulgaris; Aminolevulinic Acid; Facial Dermatoses; Female; Humans; Male; Photochemotherapy; Photosensitizing Agents; Treatment Outcome | 2016 |
[Procedure for daylight methyl aminolevulinate photodynamic therapy to treat actinic keratoses].
Topics: Aminolevulinic Acid; Clinical Protocols; Facial Dermatoses; Humans; Keratosis, Actinic; Pain; Patient Education as Topic; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Skin Cream; Sunlight; Treatment Outcome | 2016 |
Long-term efficacy and safety of daylight photodynamic therapy with methyl amninolevulinate for actinic keratosis of the face and scalp.
Topics: Aminolevulinic Acid; Facial Dermatoses; Follow-Up Studies; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Recurrence; Scalp Dermatoses; Sunlight; Treatment Outcome | 2017 |
[Retrospective, descriptive, observational study of treatment of multiple actinic keratoses with topical methyl aminolevulinate and red light: results in clinical practice and correlation with fluorescence imaging].
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Female; Fluorescence; Hand Dermatoses; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photography; Photosensitizing Agents; Retrospective Studies; Scalp Dermatoses; Treatment Outcome | 2008 |
The clinical efficacy of topical methyl-aminolevulinate photodynamic therapy in moderate to severe actinic keratoses of the face and scalp.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminolevulinic Acid; Analysis of Variance; Carcinoma, Squamous Cell; Cohort Studies; Facial Dermatoses; Female; Follow-Up Studies; Humans; Keratosis, Actinic; Male; Middle Aged; Pain Measurement; Patient Compliance; Photochemotherapy; Precancerous Conditions; Probability; Risk Assessment; Scalp Dermatoses; Severity of Illness Index; Skin Neoplasms; Treatment Failure; Treatment Outcome | 2010 |
Field treatment of facial and scalp actinic keratoses with photodynamic therapy: survey of patient perceptions of treatment satisfaction and outcomes.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Humans; Keratosis, Actinic; Middle Aged; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses | 2011 |
Colloid milium successfully treated with MAL-PDT.
Topics: Aminolevulinic Acid; Colloids; Facial Dermatoses; Humans; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Diseases | 2013 |
Allergic contact dermatitis to methyl aminolevulinate after photodynamic therapy in 9 patients.
Topics: Adult; Aged; Allergens; Aminolevulinic Acid; Dermatitis, Allergic Contact; Diagnosis, Differential; Facial Dermatoses; Female; Humans; Male; Middle Aged; Patch Tests; Photochemotherapy; Photosensitizing Agents | 2007 |